Prohost Biotech – Exclusive Biotech Research

Exclusive Market Insight

& Scientific analysis

  • Exclusive Posts
  • Industry Newsletters
  • Clinical Trials
  • Possible Takeovers
  • Technology of the Week
  • Stock Table
  • Therapeutic Vaccines
  • Development-Stage Firms
  • Genomics
  • Prohost Picks
  • And much more...
Menu
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • The Week in Review
  • Prohost Letters
  • Login / Register
    • Login
    • Register
    • Contact Us
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • The Week in Review
  • Prohost Letters
  • Login / Register
    • Login
    • Register
    • Contact Us
Home
Today’s Highlights
About the Prohost Portfolio Tables

About the Prohost Portfolio Tables

Today’s Highlights December 5, 2019

Firstly, Forty-Seven and IVERIC bio 
We remind that the two condemned stocks Forty-Seven (FTSV) and  IVERIC bio (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
Amgen (AMGN), AstraZeneca Plc (AZN), Bristol-Myers Squibb (BMY), Forty Seven Inc (FTSV), Galapagos NV (GLPG), Gilead Sciences (GILD), Illumina (ILMN), IVERIC bio (ISEE), Merck (MRK), Novartis (NVS), Regeneron (REGN), Vertex (VRTX)
December 5, 2019
Tweet Pin It

Other Articles

  • La Jolla Pharmaceutical Company Announced an Exclusive Licensing Agreement for GIAPREZA and XERAVA in Europe
    January 12, 2021 0
  • Underlining Exelixis Bright Future
    January 11, 2021 0
  • For Those Still Asking Why the CRiSPR Gene Editing Stocks are Soaring
    January 7, 2021 0
  • Inovio: Exciting News Published in The Lancet
    December 24, 2020 0

Search ProhostBiotech

Popular Links

Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) Editas Medicine Inc (EDIT) Enanta (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeuctics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seattle Genetics (SGEN) Spark Therapeutics (ONCE) Theravance Biopharma (TBPH) Vertex (VRTX) Xoma (XOMA)
  • Recent

ProhostBiotech Archive

Sign Up for Weekly Emails

Prohost Biotech – Exclusive Biotech Research Copyright © 2021.
© 2014 Prohost Biotech. All rights reserved.

Privacy Policy | Cancellation Policy | Forward Looking Statement

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy policy